{
    "nctId": "NCT03619993",
    "briefTitle": "Patient Preference for Pegfilgrastim (Neulasta\u00ae) Application Forms",
    "officialTitle": "A Comparison of Pegfilgrastim (Neulasta\u00ae) Application Via Manual Injection Versus Injection Via an On-body Injector Regarding Patient Preference and Health Economics",
    "overallStatus": "COMPLETED",
    "conditions": "Non Hodgkin Lymphoma, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 404,
    "primaryOutcomeMeasure": "Patient preference for type of pegfilgrastim application assessed via project specific survey answered after 4 applications.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with early breast cancer planned to receive 3 weekly or dose-dense anthracycline/cyclophosphamide combination or 3 weekly taxane containing chemotherapy regimen or patients with NHL planned to receive R-CHOP-14 or R-CHOP-21 immunochemotherapy as 1st-line treatment with the indication for G-CSF prophylaxis with pegfilgrastim for the prevention of FN and reduction in CIN duration. Patients have to be included before start of their (immuno-) chemotherapy.\n* ECOG (Eastern Cooperative Oncology Group) performance status 0, 1 or 2\n* Life expectancy \\> 3 months\n* Absolute neutrophil count \u2265 1.5 x 109/L\n* Ability to read and understand German\n* Signed informed consent\n\nExclusion Criteria:\n\n* Hypersensitivity to the active substance or to any of the excipients\n* Subject is currently enrolled or has not yet completed at least 30 days since ending other investigational device or drug trial(s) or is receiving investigational agent(s)\n* Active infection or any serious underlying medical condition, which would impair the ability of the patient to receive protocol treatment\n* Prior bone marrow or stem cell transplantion\n* Subject of child-bearing potential is evidently pregnant (e.g. positive HCG (Human Chorionic Gonadotropin) test) or is breast feeding\n* Subject is not using adequate contraceptive precautions.\n* Other conditions which, in the opinion of the investigator, make participation in an investigational trial of this nature a poor risk\n* Concerns for subject's compliance with the protocol procedures",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}